Stay updated with breaking news from Technology Payment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Digital health funding in 2021 far surpassed 2020’s totals, with no signs of slowing down in 2022, and the potential permanence of some regulatory flexibilities beyond the PHE are charting a course for continued digital health growth in 2022 and beyond.
Digital health funding in 2021 far surpassed 2020’s totals, with no signs of slowing down in 2022, and the potential permanence of some regulatory flexibilities beyond the PHE are charting a course for continued digital health growth in 2022 and beyond.
kras99 - stock.adobe.com The CE mark comes on the heels of Viz.ai raising $71 million in a series C round. Viz.ai’s intelligent care coordination system connects multidisciplinary care teams earlier, coordinates care, and puts patients first with the company’s software suite, which has been clinically proven to synchronize stroke care, decrease time to treatment, and greatly improve patient outcomes. Viz.ai’s flagship solution, Viz LVO, uses AI to automatically detect suspected large vessel occlusion (LVO) strokes on computed tomography angiography imaging and...
Photo by Helen King/Getty Images Healthcare experts, such as Caitlin Sheetz, director and head of Analytics for ADVI, are still combing through everything in the Center for Medicare and Medicaid Services' Hospital Inpatient Prospective Payment System and Long Term Care Hospital proposed rule released last week. There's much for hospitals to like, as the inpatient rule stabilizes reporting requirements to pre-COVID-19 levels and extends add-on payments for 14 technologies. "Everybody for the most part is pleased," Sheetz said, though it's still too early to know what hospitals will be submitti...
{{following ? "Following" : "Follow"}} Share: Scaling The Peaks Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (announced a positive readout for allergic conjunctivitis drug) Celcuity Inc. (NASDAQ: CELC) Celldex Therapeutics, Inc. CLDX) Ibere Pharmaceuticals (NYSE: IBER) Insulet Corporation (NASDAQ: PODD) Integra LifeSciences Holdings Corporation (NASDAQ: IART) IRadimed Corporation (NASDAQ: IRMD) Lantheus Holdings, Inc. (NASDAQ: LNTH) MacroGenics, Inc. (NASDAQ: MGNX) Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) NeuroPace, Inc. (NASDAQ: NPCE) (IPOed Thursday) NovoCure Limited (NASDAQ: NVCR)...